GenoTwin
Precision medicine starts with complete pathogen insights.
New York, United States · Founded 2020 · $200K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- genotwin.com
- Total Funding
- $200K
- Last Round
- $200K SeedDec 2020
- Rounds
- 1
About
GenoTwin is a next-generation genomics platform combining leading genomics expertise with data science to transform pathogen detection and immune response assessment. Their platform simultaneously profiles both pathogens and host immune determinants, achieving 98% diagnostic accuracy across 100+ pathogen types, and enables real-time surveillance integration for public health decision-making and precision treatment strategies.
Summary
GenoTwin is an Agtech company based in New York, United States, founded in 2020. It has raised $200K in total across 1 round, most recently a $200K Seed round in Dec 2020. Investors include SOSV and IndieBio.
Funding History
Dec 2020
Investors
Similar Companies
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...
Population genomics and viral surveillance company enabling health systems and public health orga...
BillionToOne develops single-molecule diagnostic tests that improve prenatal screening and help c...
Innovative genomic technologies to solve fundamental challenges in oncology
Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genotwin"><img src="https://indexed.vc/api/badge/company/genotwin" alt="GenoTwin on Indexed.vc" width="260" height="76" /></a>